Becton, Dickinson and Company (BD) and embecta are not the same corporate entity, though embecta was originally created out of BD as part of a major corporate spin-off. Following the completion of this strategic transaction, embecta became an independent, publicly traded standalone enterprise that assumed control of BD's former diabetes care business segment, carrying forward its century-long legacy in producing specialized insulin syringes and pen needles.